MusclePharm Corporation

Equities

MSLP

US6273352012

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 03:28:56 2024-04-03 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.92%		-.--%	-.--%

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Sabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022

July 12, 2022 at 05:00 pm EDT

On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.

Latest news about MusclePharm Corporation

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-10-18	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	23-10-09	CI
Motion for Asset Sale Approved for MusclePharm Corporation	23-10-03	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	23-09-26	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	23-09-08	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	23-08-31	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-08-28	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	23-08-28	CI
Bidding Procedure Approved for MusclePharm Corporation	23-08-17	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	23-07-19	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	23-06-19	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-05-26	CI
Motion for Asset Sale Filed by MusclePharm Corporation	23-05-12	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-05-10	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	23-04-16	CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	23-04-10	CI
DIP Financing Approved for MusclePharm Corporation	23-03-08	CI
Amended DIP Financing Approved for MusclePharm Corporation	23-01-23	CI
Interim DIP Financing Approved for MusclePharm Corporation	23-01-09	CI
MusclePharm Corporation Filed for Bankruptcy	22-12-15	CI
MusclePharm Appoints Gary C. Shirshac as Interim CFO	22-09-29	MT
MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial Officer	22-09-29	CI
MusclePharm Chief Financial Officer Eric Chin Resigns	22-08-23	MT
MusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the Company	22-07-28	CI
MusclePharm Corporation Announces Board Changes	22-07-28	CI

Chart MusclePharm Corporation

Duration

Period

More charts

Company Profile

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Investment Holding Companies

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Shell Companies

	1st Jan change	Capi.
MUSCLEPHARM CORPORATION	-.--%	33
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+191.37%	7.44B
SCREAMING EAGLE ACQUISITION CORP.	+5.09%	1.09B
CHURCHILL CAPITAL CORP VII	+2.10%	981M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+24.45%	797M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+11.31%	648M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies